{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:33:01Z","timestamp":1792611181550,"version":"4.5.0"},"reference-count":114,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T00:00:00Z","timestamp":1645920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Yellow fever (YF) virus still represents a major threat in low resource countries in both South America and Africa despite the presence of an effective vaccine. YF outbreaks are not only due to insufficient vaccine coverage for insufficient vaccine supply, but also to the increase in people without history of vaccination living in endemic areas. Globalization, continuous population growth, urbanization associated with inadequate public health infrastructure, and climate changes constitute important promoting factors for the spread of this virus to tropical and subtropical areas in mosquito-infested regions capable of spreading the disease. In the present review, we focus on the origin of the virus and its transmission, representing two debated topics throughout the nineteenth century, going deeply into the history of YF vaccines until the development of the vaccine still used nowadays. Besides surveillance, we highlight the urgent need of routine immunization and vaccination campaigns associated to diverse and innovative mosquito control technologies in endemic areas for YF virus in order to minimize the risk of new YF outbreaks and the global burden of YF in the future.<\/jats:p>","DOI":"10.3390\/vaccines10030372","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T20:49:03Z","timestamp":1645994943000},"page":"372","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects"],"prefix":"10.3390","volume":"10","author":[{"given":"Elena","family":"Gianchecchi","sequence":"first","affiliation":[{"name":"VisMederi Srl, Strada del Petriccio e Belriguardo, 35, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Cianchi","sequence":"additional","affiliation":[{"name":"VisMederi Srl, Strada del Petriccio e Belriguardo, 35, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Torelli","sequence":"additional","affiliation":[{"name":"IQVIA Biotech, 1700 Perimeter Park Dr, Morrisville, NC 27560, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Montomoli","sequence":"additional","affiliation":[{"name":"VisMederi Srl, Strada del Petriccio e Belriguardo, 35, 53100 Siena, Italy"},{"name":"Department of Molecular and Developmental Medicine, University of Siena, Via Aldo 3, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/jama.300.8.960","article-title":"Yellow fever: 100 years of discovery","volume":"300","author":"Staples","year":"2008","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/1806-9282.64.02.106","article-title":"Yellow fever","volume":"64","author":"Litvoc","year":"2018","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/trstmh\/tru092","article-title":"The whole iceberg: Estimating the incidence of yellow fever virus infection from the number of severe cases","volume":"108","author":"Johansson","year":"2014","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_4","unstructured":"(2021, December 29). Yellow Fever. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/yellow-fever."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Garske, T., Van Kerkhove, M.D., Yactayo, S., Ronveaux, O., Lewis, R.F., Staples, J.E., Perea, W., and Ferguson, N.M. (2014). Yellow Fever Expert Committee. Yellow Fever in Africa: Estimating the burden of disease and impact of mass vaccination from outbreak and serological data. PLoS Med., 11.","DOI":"10.1371\/journal.pmed.1001638"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40409-018-0162-y","article-title":"Yellow fever in Africa and the Americas: A historical and epidemiological perspective","volume":"24","author":"Chippaux","year":"2018","journal-title":"J. Venom. Anim. Toxins. Incl. Trop. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bryant, J.E., Holmes, E.C., and Barrett, A.D. (2007). Out of Africa: A molecular perspective on the introduction of yellow fever virus into the Americas. PLoS Pathog., 3.","DOI":"10.1371\/journal.ppat.0030075"},{"key":"ref_8","first-page":"298","article-title":"Yellow fever; history of the disease in the eighteenth and nineteenth century","volume":"60","author":"White","year":"1959","journal-title":"J. Kans. Med. Soc."},{"key":"ref_9","unstructured":"Thomas, H. (1999). The slave trade: The story of the Atlantic slave trade. Touchstone N. Y., 1440\u20131870."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0035-9203(97)90013-4","article-title":"First evidence of natural vertical transmission of yellow fever virus in Aedes aegypti, its epidemic vector","volume":"91","author":"Fontenille","year":"1997","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_11","unstructured":"Sternberg, G.M. (1890). Report of the Etiology and Prevention of Yellow Fever."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0277-9536(92)90255-O","article-title":"Yellow fever epidemics and mortality in the United States, 1693\u20131905","volume":"34","author":"Patterson","year":"1992","journal-title":"Soc. Sci. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1353\/pbm.2005.0049","article-title":"Military medicine in the Spanish-American War","volume":"48","author":"Bollet","year":"2005","journal-title":"Perspect Biol. Med. Spring."},{"key":"ref_14","first-page":"62","article-title":"Public health and sanitation in the Panama Canal Zone: A historical account, 1880\u20131915","volume":"95","author":"Guardia","year":"1983","journal-title":"Bol. Oficina Sanit. Panam."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/jama.1901.52470070017001f","article-title":"The etiology of yellow fever: An additional note","volume":"36","author":"Reed","year":"1901","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.idc.2004.01.007","article-title":"Yellow fever in the Americas","volume":"18","author":"Bryan","year":"2004","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_17","unstructured":"Strode, G.K., Bugher, J.C., Austin-Kerr, J., Smith, H.H., Smithburn, K.C., Taylor, R.M., Theiler, M., Warren, A.J., and Whitman, L. (1951). Yellow Fever, McGraw-Hill Book Co."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Beck, A., Guzm\u00e1n, H., Li, L., Ellis, B., Tesh, R.B., and Barret, A.D.T. (2013). Phylogeographic reconstruction of African yellow fever virus isolates indicates recent simultaneous dispersal into East and West Africa. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0001910"},{"key":"ref_19","unstructured":"(2021, December 29). Yellow Fever, Available online: https:\/\/www.cdc.gov\/globalhealth\/newsroom\/topics\/yellowfever\/index.html."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4269\/ajtmh.2012.11-0432","article-title":"Assessing the risk of international spread of yellow fever virus: A mathematical analysis of an urban outbreak in Asuncion, 2008","volume":"86","author":"Johansson","year":"2012","journal-title":"Am. J. Trop. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1038\/s41598-017-05186-3","article-title":"Potential risk of re-emergence of urban transmission of yellow fever virus in Brazil facilitated by competent aedes populations","volume":"7","author":"Madec","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_22","unstructured":"Simon, L.V., Hashmi, M.F., and Torp, K.D. (2021). Yellow Fever, Stat Pearls Publishing."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(99)00155-5","article-title":"Facing up to re-emergence of urban yellow fever","volume":"353","author":"Monath","year":"1999","journal-title":"Lancet"},{"key":"ref_24","unstructured":"(2021, December 23). Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news."},{"key":"ref_25","unstructured":"World Health Organization (2017). Yellow Fever Outbreak Angola, Democratic Republic of the Congo and Uganda 2016\u20132017, World Health Organization. Available online: http:\/\/www.who.int\/emergencies\/yellowfever\/en."},{"key":"ref_26","first-page":"92","article-title":"Yellow fever from Angola and Congo: A storm gathers","volume":"47","author":"Ahmed","year":"2017","journal-title":"Trop. Dr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.12688\/f1000research.11280.1","article-title":"Yellow fever in the Americas: The growing concern about new epidemics","volume":"6","year":"2017","journal-title":"F1000Research"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e67023","DOI":"10.7554\/eLife.67023","article-title":"Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries","volume":"10","author":"Gaythorpe","year":"2021","journal-title":"Elife"},{"key":"ref_29","unstructured":"World Health Organization (2017). Eliminate Yellow fever Epidemics (EYE): A global strategy, 2017\u20132026. Wkly. Epidemiol. Rec., 16, 193\u2013204."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijid.2017.11.026","article-title":"Global risk mapping for major diseases transmitted by Aedes aegypti and Aedes albopictus","volume":"67","author":"Leta","year":"2018","journal-title":"Int. J. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/trstmh\/tru043","article-title":"Yellow fever, Asia and the East African slave trade","volume":"108","author":"Cathey","year":"2014","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4269\/ajtmh.1985.34.1219","article-title":"Oral infection of Aedes aegypti with yellow fever virus: Geographic variation and genetic considerations","volume":"34","author":"Tabachnick","year":"1985","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2471\/BLT.17.205658","article-title":"Identifying Global Vulnerabilities to Urban Transmission of Yellow Fever Virus","volume":"96","author":"Brent","year":"2018","journal-title":"Bull. World Health Organ."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2471\/BLT.18.213298","article-title":"Potential yellow fever epidemics in unexposed populations","volume":"96","author":"Gubler","year":"2018","journal-title":"Bull. World Health Organ."},{"key":"ref_35","first-page":"8","article-title":"Yellow fever cases in Asia: Primed for an epidemic","volume":"489","author":"Wasserman","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41564-019-0376-y","article-title":"Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus","volume":"4","author":"Kraemer","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"taab015","DOI":"10.1093\/jtm\/taab015","article-title":"Yellow fever in Asia-a risk analysis","volume":"28","author":"Cracknell","year":"2021","journal-title":"J. Travel Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kuno, G. (2020). The absence of yellow fever in Asia: History, hypotheses, vector dispersal, possibility of YF in Asia, and other enigmas. Viruses, 12.","DOI":"10.3390\/v12121349"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1089\/vbz.2015.1804","article-title":"Infection of Mosquito Cells (C6\/36) by Dengue-2 Virus Interferes with Subsequent Infection by Yellow Fever Virus","volume":"16","author":"Abrao","year":"2016","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_40","unstructured":"Costa, E.P.A., and Fonseca, B.A.L. (2006). Dengue-2 Virus Almost Abolish Yellow Fever Virus Replication in C6\/36 Cells, Amer Soc Trop Med & Hygiene."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0035-9203(50)90009-5","article-title":"Seasonal variations in rainfall: Prevalence of Haemagogus and incidence of jungle yellow fever in Brazil and Colombia","volume":"43","author":"Kumm","year":"1950","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40794-020-0101-0","article-title":"Yellow fever control: Current epidemiology and vaccination strategies","volume":"6","author":"Chen","year":"2020","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Hamlet, A., Gaythorpe, K.A.M., Garske, T., and Ferguson, N.M. (2021). Seasonal and inter-annual drivers of yellow fever transmission in South America. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0008974"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/ele.12904","article-title":"Pathogen spillover during land conversion","volume":"21","author":"Faust","year":"2018","journal-title":"Ecol. Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3201\/eid1409.071196","article-title":"Forest Fragmentation as Cause of Bacterial Transmission among Primates, Humans, and Livestock, Uganda","volume":"14","author":"Goldberg","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Gottdenker, N.L., Chaves, L.F., Calzada, J.E., Saldana, A., and Carroll, C.R. (2012). Host Life History Strategy, Species Diversity, and Habitat Influence Trypanosoma cruzi Vector Infection in Changing Landscapes. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001884"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"cox020","DOI":"10.1093\/conphys\/cox020","article-title":"Habitat disturbance results in chronic stress and impaired health status in forest-dwelling paleotropical bats","volume":"5","author":"Seltmann","year":"2017","journal-title":"Conserv. Physiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.baae.2017.09.012","article-title":"Deforestation and vector-borne disease: Forest conversion favors important mosquito vectors of human pathogens","volume":"26","author":"Vittor","year":"2018","journal-title":"Basic Appl. Ecol."},{"key":"ref_49","first-page":"664","article-title":"Yellow fever virus outbreak in Brazil under current and future climate","volume":"6","author":"Sadeghieh","year":"2021","journal-title":"Infect. Dis. Model."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Huber, J.H., Childs, M.L., Caldwell, J.M., and Mordecai, E.A. (2018). Seasonal temperature variation influences climate suitability for dengue, chikungunya, and Zika transmission. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006451"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.chom.2021.12.009","article-title":"Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies","volume":"30","author":"Haslwanter","year":"2022","journal-title":"Cell Host Microbe"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijid.2019.07.033","article-title":"A yellow flag on the horizon: The looming threat of yellow fever to North America","volume":"87","author":"Lazcano","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s13071-014-0532-4","article-title":"Recent and projected future climatic suitability of North America for the Asian tiger mosquito Aedes albopictus","volume":"7","author":"Ogden","year":"2014","journal-title":"Parasit. Vectors"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Lowe, A.M., Forest-B\u00e9rard, K., Trudel, R., Lo, E., Gamache, P., Tandonnet, M., Kotchi, S.O., Leighton, P., Dibernardo, A., and Lindsay, R. (2021). Mosquitoes Know No Borders: Surveillance of Potential Introduction of Aedes Species in Southern Qu\u00e9bec, Canada. Pathogens, 10.","DOI":"10.3390\/pathogens10080998"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5802\/crbiol.34","article-title":"Understanding the role of arthropod vectors in the emergence and spread of plant, animal and human diseases. A chronicle of epidemics foretold in South of France","volume":"343","author":"Fontenille","year":"2021","journal-title":"Comptes Rendus Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2105\/AJPH.27.1.1","article-title":"The newer epidemiology of yellow fever","volume":"27","author":"Soper","year":"1937","journal-title":"Am. J. Public Health Nations Health"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.1991.45.1","article-title":"Yellow fever: Victor, Victoria? Conqueror, Conquest? Epidemics and research in the last forty years and prospects for the future","volume":"45","author":"Monath","year":"1991","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_58","unstructured":"Plotkin, S., Orenstein, W.A., and Offit, P. (2008). Yellow Fever. Vaccines, Elsevier. [5th ed.]."},{"key":"ref_59","unstructured":"World Health Organization (2007). Assessment of yellow fever epidemic risk\u2014A decision-making tool for preventive immunization campaigns. Wkly. Epidemiol. Rec., 82, 153\u2013160."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Rezende, I.M., Sacchetto, L., Munhoz de Mello, E., Alves, P.A., Campos de Melo Iani, F., Adelino, T.E.R., Duarte, M.M., Cury, A.L.F., Bernardes, A.F.L., and Santos, T.A. (2018). Persistence of Yellow fever virus outside the Amazon Basin, causing epidemics in Southeast Brazil, from 2016 to 2018. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006538"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.26633\/RPSP.2019.29","article-title":"Yellow fever outbreak in a rural-urban mixed community of Espirito Santo, Brazil: Epidemiological aspects","volume":"43","author":"Moussallem","year":"2019","journal-title":"Rev. Panam. Salud. Publ."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S1473-3099(17)30419-X","article-title":"Global yellow fever vaccination coverage from 1970 to 2016: An adjusted retrospective analysis","volume":"17","author":"Shearer","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_63","unstructured":"Plotkin, S.A., and Orenstein, W.A. (2004). Yellow fever vaccine. Vaccines, WB Saunders. [4th ed.]."},{"key":"ref_64","unstructured":"WHO (2013). Vaccines and vaccination against yellow fever. Wkly. Epidemiol. Rec., 88, 269\u2013283."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11908-017-0566-9","article-title":"Live attenuated yellow fever 17D vaccine: A legacy vaccine still controlling outbreaks in modern day","volume":"19","author":"Collins","year":"2017","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/14760584.2018.1406800","article-title":"The 17D-204 and 17DD yellow fever vaccines: An overview of major similarities and subtle differences","volume":"17","author":"Ferreira","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0042-6822(92)90745-B","article-title":"Heterogeneity in envelope protein sequence and N-linked glycosylation among yellow fever virus vaccine strains","volume":"188","author":"Post","year":"1992","journal-title":"Virology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1016\/j.vaccine.2017.03.032","article-title":"Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease","volume":"35","author":"Barrett","year":"2017","journal-title":"Vaccine"},{"key":"ref_69","first-page":"647","article-title":"Centers for Disease Control and Prevention (CDC). Yellow fever vaccine booster doses: Recommendations of the advisory committee on immunization practices, 2015","volume":"64","author":"Staples","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.vaccine.2011.12.133","article-title":"Aggregate travel vs. single trip assessment: Arguments for cumulative risk analysis","volume":"30","author":"Leder","year":"2012","journal-title":"Vaccine"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cid\/cis520","article-title":"Vaccine administration decision making: The case of yellow fever vaccine","volume":"55","author":"Lown","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/jtm.12119","article-title":"Preferences and decision needs of Boston-area travelers to countries with risk of yellow fever transmission: Implications for health care providers","volume":"21","author":"Lown","year":"2014","journal-title":"J. Travel Med."},{"key":"ref_73","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull. World Health Organ."},{"key":"ref_74","unstructured":"Advisory Committee on Immunization Practices (ACIP) (2021, December 29). Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Use of Yellow Fever Vaccine Booster Doses, Available online: https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/grade\/yf-vac-boost.html2015."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0035-9203(44)80006-2","article-title":"Yellow fever in the recently inoculated","volume":"38","author":"Elliott","year":"1944","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/am.25.4.539-544.1973","article-title":"Yellow fever vaccine: Direct challenge of monkeys given graded doses of 17D vaccine","volume":"25","author":"Mason","year":"1973","journal-title":"Appl. Microbiol."},{"key":"ref_77","first-page":"1","article-title":"Centers for Disease Control & Prevention. Yellow fever vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Staples","year":"2010","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/oxfordjournals.aje.a117420","article-title":"Herd immunity: Basic concept and relevance to public health immunization practises","volume":"141","author":"Fox","year":"1995","journal-title":"Am. J. Epidemiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0035-9203(52)90062-X","article-title":"Immunity to yellow fever nine years after vaccination with 17D vaccine","volume":"46","author":"Dick","year":"1952","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_80","first-page":"9","article-title":"Duration of immunity after yellow vaccination","volume":"34","author":"Courtois","year":"1954","journal-title":"Ann. Soc. Belg. Med. Trop."},{"key":"ref_81","first-page":"699","article-title":"Neutralizing and haemmaglutination-inhibiting anti-bodies to yellow fever 17 years after vaccination with 17D vaccine","volume":"27","author":"Groot","year":"1962","journal-title":"Bull. World Health Organ."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4269\/ajtmh.1963.12.230","article-title":"Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine","volume":"12","author":"Rosenzweig","year":"1963","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1016\/j.vaccine.2011.06.034","article-title":"Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model","volume":"29","author":"Julander","year":"2011","journal-title":"Vaccine"},{"key":"ref_84","unstructured":"World Health Organization (2021, December 23). Guidelines for Plaque Reduciton Neutralization Testing of Human Antibodies to Dengue Viruses. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/69687\/who_ivb_07.07_eng.pdf;jsessionid=19BF765D9B3FDAD85EF3F217B0165953?sequence=1."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/vim.2008.0007","article-title":"Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses","volume":"21","author":"Roehrig","year":"2008","journal-title":"Viral Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Efficacy and duration of immunity after yellow fever vaccination: Systematic review on the need for a booster every 10 years","volume":"89","author":"Gotuzzo","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Collaborative group for studies on yellow fever vaccines (2014). Duration of post-vaccination immunity against yellow fever in adults. Vaccine, 32, 4977\u20134984.","DOI":"10.1016\/j.vaccine.2014.07.021"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1080\/14760584.2016.1198259","article-title":"Questions regarding the safety and duration of immunity following live yellow fever vaccination","volume":"15","author":"Amanna","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Wieten, R.W., Jonker, E.F., Van Leeuwen, E.M., Remmerswaal, E.B., Ten Berge, I.J., De Visser, A.W., Van Genderen, P.J.J., Goorhuis, A., Visser, L.G., and Grobusch, M.P. (2016). A single 17D yellow fever vaccination provides lifelong immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149871"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"tay134","DOI":"10.1093\/jtm\/tay134","article-title":"Waning immunity after single-dose yellow fever vaccination: Who needs a second shot?","volume":"26","author":"Visser","year":"2019","journal-title":"J. Travel Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S1473-3099(19)30411-6","article-title":"Are booster doses of yellow fever vaccine needed?","volume":"19","author":"Vasconcelos","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Group for Studies of Yellow Fever Vaccine (2015). A randomized double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213\/77 in children nine-23 months old. Mem. Inst. Oswaldo Cruz, 110, 771\u2013780.","DOI":"10.1590\/0074-02760150176"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1016\/j.vaccine.2017.09.047","article-title":"A study of the immune response to yellow fever vaccine among infants previously immunized against measles","volume":"35","author":"Goujon","year":"2017","journal-title":"Vaccine"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S1473-3099(19)30323-8","article-title":"Long-term immunity against yellow fever in children vaccinated during infancy: A longitudinal cohort study","volume":"19","author":"Domingo","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4269\/ajtmh.1999.60.1045","article-title":"Comparison of the immunogenicity and safety of two 17D yellow fever vaccines","volume":"60","author":"Lang","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and yellow fever-VAX) in a Phase III multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0091-6749(99)70245-9","article-title":"Anaphylaxis from yellow fever vaccine","volume":"103","author":"Kelso","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_98","unstructured":"Centers for Disease Control and Prevention (2002). Yellow fever vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep., 51, 4\u20136."},{"key":"ref_99","unstructured":"Centers for Disease Control and Prevention (2007, January 25). Yellow Fever Vaccine Information Statement, Available online: http:\/\/www.cdc.gov\/nip\/publications\/VIS\/vis-yf.pdf."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.SMJ.0000157537.11806.DC","article-title":"Rare case of fatal yellow fever vaccine-associated viscerotropic disease","volume":"98","author":"Gerasimon","year":"2005","journal-title":"South. Med. J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3201\/eid0706.010605","article-title":"Advanced age a risk factor for illness temporally associated with yellow fever vaccination","volume":"7","author":"Martin","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(04)17017-7","article-title":"Yellow Fever Vaccine Safety Working Group. History of thymoma and yellow fever vaccination","volume":"364","author":"Eidex","year":"2004","journal-title":"Lancet"},{"key":"ref_103","unstructured":"World Health Organization (2016). Fractional Dose Yellow Fever Vaccine as a Dose-Sparing Option for Outbreak Response, World Health Organization. Available online: http:\/\/apps.who.int\/iris\/bitstream\/10665\/246236\/1."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Roukens, A.H., Vossen, A.C., Bredenbeek, P.J., Van Dissel, J.T., and Visseret, L.G. (2008). Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: A randomized controlled non-inferiority trial. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001993"},{"key":"ref_105","unstructured":"Plotkin, S.A., Orenstein, W.A., Offit, P.A., and Edwards, K.M. (2018). Vaccine immunology. Plotkin\u2019s Vaccines, Elsevier. [7th ed.]."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4161\/hv.22982","article-title":"17DD yellow fever vaccine: A double blind, randomized clinical trial of immunogenicity and safety on a dose-response study","volume":"9","author":"Martins","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/taz024","article-title":"Fractional-dose yellow fever vaccination: An expert review","volume":"26","author":"Roukens","year":"2019","journal-title":"J. Travel Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMp1803433","article-title":"Fractional-Dose Yellow Fever Vaccination\u2014Advancing the Evidence Base","volume":"379","author":"Vannice","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJMoa1710430","article-title":"Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak\u2014Final Report","volume":"381","author":"Casey","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_110","unstructured":"(2021, December 29). Yellow Fever Supply and Procurement Roadmap. Available online: https:\/\/www.gavi.org\/about\/market-shaping\/supply-and-procurement-roadmaps\/."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4269\/ajtmh.16-0293","article-title":"Plant-produced subunit vaccine candidates against yellow fever induce virus neutralizing antibodies and confer protection against viral challenge in animal models","volume":"98","author":"Tottey","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1017\/S0950268818002273","article-title":"Is vaccinating monkeys against yellow fever the ultimate solution for the Brazilian recurrent epizootics?","volume":"146","author":"Massad","year":"2018","journal-title":"Epidemiol. Infect."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Achee, N.L., Grieco, J.P., Vatandoost, H., Gon\u00e7alo Seixas, G., Pinto, J., Lee Ching-Ng, L., Martins, A.J., Juntarajumnong, W., Corbel, V., and Gouagna, C. (2019). Alternative strategies for mosquito-borne arbovirus control. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007275"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2214-109X(18)30024-X","article-title":"Existing and potential infection risk zones of yellow fever worldwide: A modelling analysis","volume":"6","author":"Shearer","year":"2018","journal-title":"Lancet Glob. Health"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/3\/372\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:28:52Z","timestamp":1760135332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/3\/372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,27]]},"references-count":114,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["vaccines10030372"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10030372","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,27]]}}}